Trial intelligence / Profile preview

Fibrinogen infusion to reduce bleeding during spine surgery

IRCT201307304969N8Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Sep 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of Fibrinogen human in Massive hemorrhage, sponsored by Iran University of Medical Sciences. Started Sep 2012; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

Massive hemorrhage

Beyond the preview

Go deeper on IRCT201307304969N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201307304969N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call